Home

What We Treat

About Us

Room & Facilities

Meet the Team

Admission

FAQ’s

Our Program

Treatment Costs

Resources

What is addiction
Type of addiction
Choosing a Rehab
Asking for help
Help for families

Blog

Contact Us

Alcohol Addiction

Guiding you through effective treatment and recovery strategies.

Intervention Technique
Sign of alcohol addiction
Rehab & Treatment
Alcohol Withdrawal Symptoms
Mixing Drugs with alcohol

View All Alcohol Addiction

Drugs Addictions

Focused on successful treatment approaches for drug addictions.

Antidepressant addiction
Benzo Addiction
Stimulant Addiction
Marijuana Addiction
Opioid Addiction

View All Drugs Addiction

Process Addictions

Offering treatment insights for a range of behavioral addictions.

Gambling Addiction & Abuse

Porn Addiction

Sex Addiction

Internet Addiction

Relationship Addiction

View All Process Addiction

Mental Health

Treatment options and strategies for mental health improvement.

Mental Health Treatment
Depression Treatment
Insomnia Treatment
PTSD treatment

View All Mental Health

SAFE, MEDICALLY MANAGED OPIOID DETOX IN THAILAND

Opioid Addiction Withdrawal

Opioid withdrawal is a predictable physiological response to discontinuing chronic opioid use. Medically supervised detoxification at Phuket Island Rehab reduces symptom severity by up to 70 percent and provides a safe foundation for long-term recovery.

Key Takeaway: Opioid withdrawal follows a predictable timeline determined by the half-life of the specific opioid used. Medically supervised detox using buprenorphine protocols reduces symptom severity, prevents dangerous complications, and significantly improves the likelihood of transitioning successfully into ongoing treatment.

What Is Opioid Withdrawal?

Opioid withdrawal is the collection of physical and psychological symptoms that occur when a person who has developed physical dependence on opioids reduces or stops their use. It is a direct consequence of neuroadaptation: chronic opioid exposure causes the brain to downregulate its own endorphin production and adjust neurotransmitter systems to compensate for the constant presence of exogenous opioids. When the drug is removed, these compensatory changes are unmasked, producing a state of physiological hyperexcitability.

The withdrawal syndrome is mediated primarily by the locus coeruleus, a brainstem nucleus rich in noradrenergic neurons. During chronic opioid use, opioids suppress locus coeruleus activity. When opioids are withdrawn, the locus coeruleus fires at dramatically increased rates, releasing a surge of noradrenaline that drives many of the classic withdrawal symptoms: anxiety, agitation, muscle cramps, sweating, tachycardia, and hypertension.

While opioid withdrawal is extremely uncomfortable, it is rarely fatal in otherwise healthy adults when managed in a medical setting. However, complications can arise from severe dehydration (due to vomiting and diarrhoea), aspiration, and cardiac arrhythmias in individuals with pre-existing conditions. The primary danger of unmanaged withdrawal is not the withdrawal itself but the extremely high relapse rate: over 80 percent of individuals who attempt to detox without medical support return to opioid use, often at doses their reduced tolerance can no longer safely handle.

Opioid Withdrawal Timeline

The onset, peak, and duration of opioid withdrawal depend on the pharmacokinetic properties of the specific opioid. Short-acting opioids such as heroin, oxycodone, and morphine produce withdrawal symptoms within 6 to 12 hours of the last dose, with symptoms peaking at 36 to 72 hours and acute symptoms generally resolving within 5 to 7 days. Long-acting opioids like methadone may not trigger withdrawal for 24 to 48 hours, with peak symptoms at 72 to 96 hours and a total duration extending to 14 to 21 days.

Phase Timeline (Short-Acting) Predominant Symptoms
Early withdrawal 6 to 24 hours Anxiety, restlessness, muscle aches, yawning, lacrimation, rhinorrhoea, sweating
Peak withdrawal 36 to 72 hours Nausea, vomiting, diarrhoea, abdominal cramps, tachycardia, hypertension, insomnia, piloerection
Late acute withdrawal Day 4 to 7 Gradual symptom reduction, persistent insomnia, fatigue, low mood, mild GI symptoms
Post-acute (PAWS) Weeks to months Insomnia, anxiety, dysphoria, anhedonia, drug cravings, poor concentration

Physical Symptoms of Opioid Withdrawal

The physical symptoms of opioid withdrawal are driven by noradrenergic hyperactivity and the sudden absence of opioid-mediated inhibition across multiple organ systems. The gastrointestinal tract is particularly affected because the enteric nervous system contains a high density of opioid receptors. Chronic opioid use suppresses gut motility (causing constipation), and withdrawal produces a rebound effect with severe abdominal cramping, nausea, vomiting, and diarrhoea.

Musculoskeletal symptoms include deep, aching pain in the muscles and joints, often described as feeling like severe influenza. This occurs because opioids mask the body’s normal pain signals, and withdrawal unmasks both the original pain pathways and the opioid-induced hyperalgesia that develops during chronic use. Restless legs syndrome is another common and highly distressing symptom, interfering severely with sleep.

Autonomic nervous system dysregulation produces sweating, chills, piloerection (goosebumps, colloquially called “cold turkey”), tachycardia, hypertension, and temperature fluctuations. Yawning, lacrimation (excessive tearing), and rhinorrhoea (runny nose) are among the earliest signs and serve as reliable clinical indicators that withdrawal has begun.

Clinical Insight: The Clinical Opiate Withdrawal Scale (COWS) is the standard assessment tool used to quantify withdrawal severity. Scores range from 0 (no withdrawal) to 48 (severe withdrawal). Buprenorphine induction at Phuket Island Rehab is typically initiated when the COWS score reaches 8 to 12, indicating mild to moderate withdrawal, to avoid precipitated withdrawal while ensuring adequate receptor occupancy.

Psychological Symptoms of Opioid Withdrawal

The psychological symptoms of opioid withdrawal are often more distressing and longer-lasting than the physical symptoms. Severe anxiety and agitation dominate the acute phase, driven by locus coeruleus hyperactivation and the sudden loss of opioid-mediated emotional dampening. Dysphoria, an intense state of unease and emotional pain, is mediated by disruption of the mesolimbic dopamine system, which has been downregulated by chronic opioid exposure.

Insomnia is among the most persistent symptoms, often lasting weeks beyond the resolution of physical withdrawal. It is caused by disruption of sleep architecture, particularly the loss of opioid-facilitated slow-wave sleep. Irritability, difficulty concentrating, and emotional lability (rapid mood shifts) reflect the prefrontal cortex’s impaired capacity for emotional regulation during early recovery.

Post-acute withdrawal syndrome (PAWS) refers to a protracted phase of psychological symptoms that can persist for three to six months or longer after the last opioid dose. PAWS includes persistent low mood, anhedonia, anxiety, cognitive fog, and intermittent cravings. Understanding PAWS is critical because many individuals misinterpret these symptoms as permanent or as evidence that they cannot function without opioids, leading to relapse.

Warning: The highest risk of fatal overdose occurs in the days and weeks immediately following withdrawal, when physical tolerance has dropped significantly but psychological cravings remain intense. If a person who has recently detoxed returns to their pre-withdrawal dose, respiratory arrest can occur. Naloxone should be accessible to anyone in early recovery from opioid use disorder.

Medically Supervised Detox at Phuket Island Rehab

Medically supervised opioid detoxification at Phuket Island Rehab follows evidence-based protocols designed to minimise discomfort, prevent complications, and create a stable foundation for ongoing therapeutic work. The detox process is not treated as a standalone intervention but as the first integrated phase of a comprehensive residential treatment programme.

The buprenorphine induction protocol begins once early withdrawal symptoms are confirmed via COWS assessment. An initial dose of 2 to 4 mg sublingual buprenorphine is administered, with supplementary doses given at two-hour intervals as needed to control symptoms, up to a maximum first-day dose determined by the treating physician. On subsequent days, the dose is titrated to achieve stable symptom control, typically reaching a maintenance dose of 8 to 16 mg per day. This dose is then gradually tapered over the course of the detox period or transitioned to maintenance therapy depending on the individual treatment plan.

Adjunctive medications form an essential component of the detox protocol. Clonidine patches or oral doses manage autonomic hyperactivity. Ondansetron controls nausea. Loperamide addresses diarrhoea. Gabapentin or hydroxyzine provides anxiolytic effects without addiction risk. Trazodone or melatonin supports sleep restoration. Ibuprofen manages musculoskeletal pain. This combination approach addresses each symptom cluster simultaneously, producing a substantially more comfortable withdrawal experience.

Twenty-four-hour nursing monitoring ensures that vital signs (heart rate, blood pressure, respiratory rate, temperature) are tracked throughout the withdrawal period, and the medical team can intervene immediately if complications arise. Intravenous fluid replacement is available for individuals experiencing significant dehydration from vomiting or diarrhoea.

Medication Target Symptom Mechanism
Buprenorphine Overall withdrawal severity, cravings Partial mu-opioid agonist
Clonidine Sweating, tachycardia, hypertension, anxiety Alpha-2 adrenergic agonist
Ondansetron Nausea, vomiting 5-HT3 receptor antagonist
Loperamide Diarrhoea Peripheral mu-opioid agonist (non-CNS)
Trazodone Insomnia Serotonin antagonist and reuptake inhibitor
Gabapentin Anxiety, restless legs, neuropathic pain GABA analogue, calcium channel modulation

Transitioning from Withdrawal to Ongoing Treatment

The completion of acute detoxification marks the beginning, not the end, of opioid addiction treatment. At Phuket Island Rehab, clients transition directly from the detox unit into the residential therapeutic programme without a gap in care. This seamless transition is critical because the period immediately following detox is characterised by residual physical discomfort, elevated craving intensity, and psychological vulnerability.

The residential programme provides the structured environment, therapeutic support, and peer connection that sustain recovery during the weeks and months when the brain’s reward circuitry is still healing. Individual and group therapy sessions begin as soon as the client is physically stable enough to engage, typically within the first week of detox. Early therapeutic engagement has been shown to improve treatment retention and long-term outcomes.

For clients who will continue on medication-assisted treatment, the buprenorphine dose established during detox can be maintained or adjusted during the residential phase, with a tapering plan developed collaboratively between the client and the medical team. Alternatively, clients who are appropriate candidates for naltrexone can be transitioned after a minimum opioid-free period, with the extended-release injectable formulation providing 30 days of continuous blockade per dose.

Key Point: Opioid withdrawal is a manageable medical process when supervised by experienced clinicians. The fear of withdrawal is one of the most significant barriers to seeking treatment. Understanding that modern detox protocols can reduce symptom severity by 60 to 70 percent may help individuals take the first step toward recovery.

Frequently Asked Questions

How long does opioid withdrawal last?

Acute physical withdrawal from short-acting opioids (heroin, oxycodone) typically peaks at 36 to 72 hours and resolves within 5 to 7 days. Long-acting opioids (methadone) may produce withdrawal lasting 14 to 21 days. Post-acute withdrawal symptoms including insomnia, mood disturbance, and cravings can persist for three to six months but gradually diminish with ongoing treatment support.

Is opioid withdrawal dangerous?

Opioid withdrawal is rarely life-threatening for otherwise healthy adults when medically supervised. However, severe dehydration from vomiting and diarrhoea can cause electrolyte imbalances and cardiac complications if not managed. The most serious risk is not the withdrawal itself but the dramatically increased overdose risk if the person relapses after tolerance has dropped.

Can I detox from opioids at home?

Home detox is strongly discouraged for moderate to severe opioid dependence. Without medical support, the intense discomfort of withdrawal drives relapse rates above 80 percent, and the risk of fatal overdose following a relapse with reduced tolerance is substantial. Medically supervised detox provides symptom management, safety monitoring, and a direct pathway into therapeutic treatment.

What is precipitated withdrawal?

Precipitated withdrawal occurs when an opioid antagonist or partial agonist (such as buprenorphine or naloxone) is administered while full-agonist opioids are still occupying receptors. The antagonist rapidly displaces the full agonist, causing sudden, severe withdrawal symptoms within minutes. This is why buprenorphine induction must be timed carefully, beginning only after early withdrawal symptoms have emerged naturally.

What is post-acute withdrawal syndrome (PAWS)?

PAWS refers to a protracted phase of withdrawal-related symptoms that persists beyond the acute withdrawal period. Symptoms include low mood, anxiety, insomnia, poor concentration, anhedonia, and intermittent cravings. PAWS reflects the ongoing neurobiological recovery of brain systems altered by chronic opioid exposure and typically improves gradually over three to six months with appropriate treatment support.

Clinical Reviewer: Dr. Ponlawat Pitsuwan, Physician | Publisher: Phuket Island Rehab | Last Updated: April 2026 | Clinical Entities: Opioid withdrawal syndrome, locus coeruleus, buprenorphine, Clinical Opiate Withdrawal Scale (COWS), post-acute withdrawal syndrome, noradrenergic hyperactivity, naloxone, clonidine, gabapentin

Start Your Recovery in Phuket, Thailand

Pricing & Information

This field is for validation purposes and should be left unchanged.
Your Name(Required)
Privacy Policy(Required)